Methods for improving stent retention on a balloon catheter

Information

  • Patent Grant
  • 10342688
  • Patent Number
    10,342,688
  • Date Filed
    Wednesday, January 11, 2017
    7 years ago
  • Date Issued
    Tuesday, July 9, 2019
    5 years ago
Abstract
A method of crimping a stent on a balloon of a catheter assembly is provided. A polymeric stent is disposed over a balloon in an inflated configuration. The stent is crimped over the inflated balloon to a reduced crimped configuration so that the stent is secured onto the balloon. The balloon wall membrane is wedged or pinched between the strut elements of the stent for increasing the retention of the stent on the balloon.
Description
TECHNICAL FIELD

This invention relates to methods of crimping or mounting a stent on a balloon of a catheter assembly.


BACKGROUND

A stent, as illustrated in FIG. 1, is an intravascular prosthesis that is delivered and implanted within a patient's vasculature or other bodily cavities and lumens by a balloon catheter. For example, stents can be used in percutaneous transluminal coronary angioplasty (PTCA) or percutaneous transluminal angioplasty (PTA). Conventional stems and catheters are disclosed by U.S. Pat. Nos. 4,733,665, 4,800,882, 4,886,062, 5,514,154, 5,569,295, and 5,507,768. In advancing a stent through a body vessel to a deployment site, the stent must be able to securely maintain its axial as well as rotational position on the delivery catheter without translocating proximally or distally, and especially without becoming separated from the catheter. Stents that are not properly secured or retained to the catheter may slip and either be lost or be deployed in the wrong location. The stent must be “crimped” in such a way as to minimize or prevent distortion of the stent and to thereby prevent abrasion and/or reduce trauma to the vessel walls.


Generally, stent crimping is the act of affixing the stent to the delivery catheter or delivery balloon so that it remains affixed to the catheter or balloon until the physician desires to deliver the stent at the treatment site. Current stent crimping technology is sophisticated. Examples of such technology which are known by one of ordinary skill the art include a roll crimper; a collet crimper; and an iris or sliding-wedge crimper. To use a roll crimper, first the stent is slid loosely onto the balloon portion of the catheter. This assembly is placed between the plates of the roll crimper. With an automated roll crimper, the plates come together and apply a specified amount of force. They then move back and forth a set distance in a direction that is perpendicular to the catheter. The catheter rolls back and forth this motion, and the diameter of the stent is reduced. The process can be broken down into more than one step, each with its own level of force, translational distance, and number of cycles. This process imparts a great deal of shear to the stent in a direction perpendicular to the catheter or catheter wall. Furthermore, as the stent is crimped, there is additional relative motion between the stent surface and the crimping plates.


The collet crimper is equally conceptually simple. A standard drill-chuck collet is equipped with several pie-piece-shaped jaws. These jaws move in a radial direction as an outer ring is turned. To use this crimper, a stent is loosely placed onto the balloon portion of a catheter and inserted in the center space between the jaws. Turning the outer ring causes the jaws to move inward. An issue with this device is determining or designing the crimping endpoint. One scheme is to engineer the jaws so that when they completely close, they touch and a center hole of a known diameter remains. Using this approach, turning the collet onto the collet stops crimps the stent to the known outer diameter. While this seems ideal, it can lead to problems. Stent struts have a tolerance on their thickness. Additionally, the process of folding non-compliant balloons is not exactly reproducible. Consequently, the collet crimper exerts a different amount of force on each stent in order to achieve the same final dimension. Unless this force, and the final crimped diameter, is carefully chosen, the variability of the stent and balloon dimensions can yield stent or balloon damage.


In the sliding wedge or iris crimper, adjacent sections move inward and twist, much like the leaves in a camera aperture. This crimper can be engineered to have two different types of endpoints. It can stop at a final diameter, or it can apply a fixed force and allow the final diameter to float from the discussion on the collet crimper, there are advantages in applying a fixed level of force as variability in strut and balloon dimension will not change the crimping force. The sliding wedges impart primarily normal forces. As the wedges slide over each other, they impart some tangential force. Lastly, the sliding wedge crimper presents a nearly cylindrical inner surface to the stent, even as it crimps. This means the crimping loads are distributed over the entire outer surface of the stent.


All current stent crimping methods were developed for all-metal stents. Stent metals, such as stainless steel, are durable and can take abuse. When crimping is too severe, it usually damages the underlying balloon, not the metal stent. But polymeric stents present different challenges. A polymer stent requires relatively wider struts than metal stents so as to provide suitable mechanical properties, such as radial strength. At the crimping stage, less space is provided between the struts which can result in worse stent retention than a metallic stent. Moreover, the use of high processing temperature during the crimping process to enhance stent retention may not be possible as a polymeric stent may have a glass transition temperature generally equivalent to the glass transition temperature of the balloon. Higher processing temperatures may cause the stent to lose some of its preferred mechanical properties.


The present invention provides a novel method of crimping a stent, more specifically a polymeric stent on an expandable member or a balloon.


SUMMARY

In accordance with one embodiment, a method of crimping a stent on a balloon of a catheter assembly is provided, comprising: providing a polymeric stent disposed over a balloon in an inflated configuration; and crimping the stent over the inflated balloon to a reduced crimped configuration so that the stent is secured onto the balloon. In some embodiments, the act of providing comprises inserting a balloon in a collapsed configuration into a stent; and expanding the balloon to the inflated configuration, wherein the inflated configuration is equal to or less than the intended expansion configuration of the balloon. In some embodiments, the inflated configuration is a configuration which provides for a membrane or wall of the balloon to protrude into gaps between structural elements of the stent. As a result, subsequent to crimping the stent on the balloon, a membrane or wall of the balloon is pinched or wedged between the structural elements of the stent. During the crimping process, the pressure in the balloon can be controllably released by a valve. In some embodiments, the stent is not a metallic stent. In some embodiments, the stent is a biodegradable polymeric stent. In some embodiments, the stent is a biodegradable polymeric stent with or without a biodegradable metallic component.


In accordance with another embodiment, a method of crimping a stent on a balloon, is provided comprising the following acts in the order as listed: (a) providing a stent disposed over a balloon in an inflated configuration; (b) crimping the stent to a first reduced diameter; (c) at least partially deflating the balloon; (d) inflating the balloon to at least an inner diameter of the stent; and (e) crimping the stent to a second reduced diameter. The second reduced diameter can be the final crimped diameter.





DESCRIPTION OF FIGURES

The figures have not been drawn to scale and portions thereof have been under or over emphasized for illustrative purposes.



FIG. 1 illustrates an example of a stent;



FIGS. 2A, 2B1, 2B2, 2C, 2D, and 2E (collectively referred to as FIG. 2) illustrate methods for crimping a stent on a balloon of a catheter;



FIG. 3 illustrates an embodiment of the end result of a stent/catheter assembly produced in accordance with a method of the invention;



FIGS. 4A and 4B are photographs of a stent crimped on a balloon in accordance with an embodiment of the invention; and



FIG. 5 is a graph illustrating the result of the Example.





DESCRIPTION

The stent crimping methods are suitable to adequately and uniformly crimp a balloon expandable stent onto a balloon or expandable member of a catheter assembly. The embodiments of the invention are also applicable to self-expandable stents and stent-grafts. In one embodiment, the method of the present invention is particularly directed to crimping of a biodegradable, polymeric stent on a balloon of a catheter assembly. A biodegradable polymer stent has many advantages over metal stents, including the ability to be placed in the body only for the duration of time until the intended function of the stent has been performed. However, retention of a polymer stent has been proven to be more challenging than that of a metallic stent. Polymer stents can require wider struts than metal stents so as to provide suitable mechanical properties, such as radial strength, for the stent. At the crimping stage, less space is provided between the struts which can result in worse stent retention than a metallic stent. Moreover, the use of high processing temperature during the crimping process to enhance stent retention may not be possible as a polymeric stent may have a glass transition temperature generally equivalent to, or lower than the glass transition temperature of the balloon. Higher processing temperatures may cause the polymeric stent to lose some of its preferred mechanical properties.



FIG. 2A illustrates an expandable member, such as a balloon 10, integrated at a distal end of a catheter assembly 12. In some embodiments, the balloon 10 is intended to include any type of enclosed member such as an elastic type member that is selectively inflatable to dilate from a collapsed configuration to a desired and controlled expanded configuration. The balloon 10 should also be capable of being deflated to a reduced profile or back to its original collapsed configuration. The balloon 10 can be made from any suitable type of material and can be of any thickness so long as the ability to crimp the stent on to the balloon and optimum performance capabilities of the balloon are not adversely compromised. Performance properties include, for example, high burst strength, good flexibility, high resistance to fatigue, an ability to fold, and ability to cross and re-cross a desired region of treatment or an occluded region in a bodily lumen, and a low susceptibility to defects caused by handling and crimping, among other possibilities.


The balloon is illustrated in FIG. 2A in a collapsed configuration. The collapsed configuration can be the configuration that is conventionally used during the process of crimping of a stent on a balloon. The balloon 10 includes no liquid or gas in the internal chamber of the balloon 10 and includes regions where the balloon material is folded over giving the balloon a crease-like appearance. Such collapsed configuration can be the configuration of introduction and navigation of the balloon 10 in the vascular system of a patient.


As illustrated in FIG. 2B1, a stent 14 is positioned over the balloon 10. The stent 14 is illustrated to have struts 16 separated by gaps 18 (as can also be seen in FIG. 1). In some embodiments, the diameter of the stent 14 as positioned over the collapsed balloon 10 is much larger than the collapsed diameter of the balloon 10. In some embodiments, as illustrated in FIG. 2B2, the diameter of the stent 14 is large enough so that an operator is capable of slipping the stent 14 over the balloon 10 with minimal gap or space between the balloon 10 and the stent 14. The balloon 10 can be inflated to a crimp inflation state before being placed into a crimping device 20 (FIG. 2D) or after being placed into the crimping device 20. The crimp inflation state is a state greater than the collapsed configuration and is a state equal to or less than the intended expansion configuration or use state. The intended expansion configuration is defined as inflation of a balloon to a diameter or size within the range of its intended use or design. The intended expanded configuration is provided by the manufacturer of the balloon or can be determined by one having ordinary skill in the art and is intended to include the range of diameter of use or the range of pressure to be applied for the planned performance of the balloon. In some embodiments, the balloon's intended use state is up to the threshold inflated configuration where the balloon becomes damaged or disapproved for use if the balloon was inflated more.


The balloon 10 can be inflated by application of a fluid or a gas. The temperature of the fluid or gas can be adjusted to other than ambient or room temperature. In one embodiment, a heated fluid or gas is used. In some embodiments, heated can be defined as above 25 deg. C. In some embodiments, the temperature can be below 200 deg. C., or alternatively below 150 deg. C., or alternatively below 100 deg. C., or alternatively below 75 deg. C. In some embodiments, the temperature can be between 25 deg. C. and 100 deg. C. In some embodiments, the temperature is equal to or above the glass transition temperature (Tg) of a polymer of the stent body or a polymer of the stent coating (if applicable). In some embodiments, the temperature is equal to or above Tg but less than melting temperature of the melting temperature of the of a polymer of the stent body or a polymer of the coating. In some embodiments, a cooled or chilled fluid or gas can be used to inflate the balloon. Cooled can mean below 25 deg. C. Chilled can mean below 0 deg. C.


In some embodiments, the crimped inflation state can include hyper-inflation of the balloon. Over or hyper-inflation is defined as any diameter or size above the intended expanded configuration but less than a diameter or size which the balloon will be damaged or no longer suitable or its intended use. Balloon diameter tolerances depend on the type of balloon and the material from which the balloon is made, among other factors. The manufacturer of the balloon can provide such information to a user, for example.


As illustrated in FIG. 2C, when the balloon 10 is inflated, it is preferred for the balloon wall or membrane to protrude out, as shown by reference number 22, from the gaps 18 between the stent struts 16. In one embodiment, the protrusion 22 should not extend beyond the outer surface of the struts 16. Alternatively, the protrusion 22 can extend beyond the outer surface of the struts 16. This ensures that the balloon wall or membrane becomes adequately wedged, lodged, squeezed, or pinched between the struts 16 when the crimping process is completed.


Next, as illustrated in FIG. 2D, the balloon 10 and the stent 14 are placed in the crimping device 20. Again, the balloon 10 can be inflated after being placed in the crimping device. The stent 14 can be positioned in the device 20 and held in place by application of pressure from the crimping device 20. The balloon 10 is then inserted within the stent 14. The balloon 10 is then inflated. The balloon 10 can be inflated to the inner diameter of the stent 14 or the diameter of the crimping device 20. In some embodiments, the balloon 10 can radially expand the stent 14 to a certain degree. The crimp device 20 then applies inward radial pressure to the stent 14 on the balloon 10.


The crimping device 20 can be any device used in the art. The stent 14 positioned over the balloon 10 is crimped to a reduced balloon and stent configuration (reduced crimped configuration), as illustrated in FIG. 2E. The reduced crimped configuration can be the final, desired configuration (i.e., the configuration used to introduce the device into the patient). Alternatively, reduced crimped configuration can be any configuration such that further crimping is needed. In one embodiment, the stent 14 is reduced in diameter, the balloon 10 is deflated (such as by application of a vacuum) and then re-inflated to the inner diameter of the stent 14 or diameter of the crimper. This is followed by further application of pressure by the crimping device 20. The process of application of pressure by the crimper, deflation of the balloon, re-inflation of the balloon, and application of pressure can be any number of times until the final, desired crimped state is achieved.


Crimping can be defined as the process of mounting, fastening or securing a stent on a balloon. The stent can be fixedly carried by the balloon but can be deployed by inflation and subsequent withdrawal of the balloon in order to be implanted at a target site, such as a region of stenosis. The crimp process can include selectively, radially compressing or applying pressure for positioning a stent on a balloon of a catheter assembly or an expandable delivery member of a catheter assembly. The compression or radial pressure during crimping can be segmented or uniform across the length and/or circumference of the stent. The application of pressure by the crimping device 20 can be continuous or applied in an intermittent or stepwise fashion. In an intermittent embodiment, the balloon can be deflated and re-inflated until final crimp configuration has been achieved. In some embodiments, the crimping device can hold the pressure at the reduced crimped configuration for duration of time prior to release of pressure. The process of crimping can also include, unless otherwise specifically indicated, modification made to the stent and/or balloon prior, during or subsequent to the application of crimping pressure that are directed to retention of the stent on the balloon. For example, the balloon can be coated before crimping to improve the retention of the stent on the balloon. In some embodiments, the balloon can be dipped into a fluid or solvent such as acetone before sliding the stent on the balloon in order to soften the balloon material. This makes it easy for the balloon material to squeeze into the space between the struts or structural elements. The solvents, such as acetone, may also partially dissolve the surface of the stent or coating on the stent allowing for better adhesion between the stem and the balloon. In some embodiments, a softening fluid can be used that is a non-solvent for the stent or the coating on the sent. By way of another example, a grip process can be conducted after crimping to further increase stent retention. An outer sleeve restrains the crimped stent. Simultaneously, pressure and heat are applied to the stent section. Under this action, the balloon material deforms slightly, moving in between the struts.


Reduced balloon configuration (i.e., reduced crimp configuration) is a size or diameter greater than the size or diameter of the balloon 10 in its collapsed configuration. In some embodiments, the measured reduced size or diameter can be equivalent or generally equivalent to that of the collapsed configuration. Since the balloon 10 is pressurized by a fluid or gas, a pressure release valve 24 is provided to allow release of pressure from the balloon 10 during the crimping process. During the crimping process, the pressure release valve 24 will open to release pressure when the compression pressure caused by the crimping is higher than a set value of the valve 24. The release of the pressure is controlled so as to allow the crimper 20 to apply adequate pressure on the stent 14 for fastening the stent 14 on the balloon 10. If too much pressure is released from the balloon 10 during crimping, the stent 14 may not be adequately crimped on the balloon 10. The set pressure value of the valve depends on a variety of factors including the type of crimping device, stent, and balloon used. The calculation of the amount of applied pressure and preset valve pressure intake can be readily determined by one having skilled in the art.


As illustrated in FIG. 3, the balloon 10, in a reduced configuration, has the stent 14 tightly crimped thereon. Balloon folds 22 have been tightly lodged, squeezed, wedged or pinched between the struts 16 of the stent 14. As the stent 14 is crimped, the struts 16 are shifted or brought closer together, causing the balloon wall or membrane 22 to be pinched between the struts 16. As for the end ring(s) of the stent 14, the balloon wall membrane 22 can be disposed between the structural elements of the stent as well. FIGS. 4A and 4B are two photographs which illustrate this crimping configuration in accordance to some embodiment of the present invention. As illustrated by the photographs, balloon wall or membrane is wedged between the structural elements of the stent


In some embodiments, the stent 14 is arranged on the balloon 10 so that an outside surface of the balloon 10 and an inside surface of the stent 14 contact each other to form a combination of the balloon and stent. In some embodiments, the outer surface of the balloon or the inner surface of a stent can include a coating such as an adhesive coating, a drug delivery coating, a protective coating, a polymeric coating, a blocking agent or the like. The blocking agent is intended to reduce adhesion and/or friction between the stent 14 or a coating on the stent 14 and the balloon 10.


The stent body itself is preferably made from a polymeric material such as one or a combination of polymers. In some embodiments, such body can be made from a combination of polymeric and metallic material(s). In some embodiments, the stent is biodegradable. Both polymers and metallic materials can be biodegradable. In one preferred embodiment, the stent is completely or exclusively made from a polymeric material or combination of polymeric materials, more specifically biodegradable polymer(s). A polymeric stent can include some metallic components for allowing the stent to be viewed during the procedure; however, the amount of material is insignificant, does not impart any structural function to the stent, or for viewing means only such that the stent is in essence made from a polymeric material or combination of polymers as is understood by one having ordinary skill in the art. In some embodiments, metallic stents are completely excluded from any of the embodiments of this invention. Metallic stents have a stent body (i.e., struts or structural elements) made mostly or completely from a metallic material such as an alloy. It should be noted that biodegradable is intended to include bioabsorbable, bioerodable, etc. unless otherwise specifically indicated.


In some embodiments, the stent can include a drug coating. The coating can be a pure drug or combination of drugs. The coating can include a polymeric carrier of a single or multiple polymers. The coating can be layered as is understood by one of ordinary skilled in the art.


The stent or the coating can be made from a material including, but are not limited to, poly(N-acetylglucosamine) (Chitin), Chitosan, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(caprolactone), poly(trimethylene carbonate), polyester amide, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, biomolecules (such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers other than polyacrylates, vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers, polyurethanes, rayon, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose. Another type of polymer based on poly(lactic acid) that can be used includes graft copolymers, and block copolymers, such as AB block-copolymers (“diblock-copolymers”) or ABA block-copolymers (“triblock-copolymers”), or mixtures thereof.


Additional representative examples of polymers that may be especially well suited for use in fabricating or coating the stent include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluororpropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), ethylene-vinyl acetate copolymers, and polyethylene glycol.


Example 1

A first polymer stent was crimped by in-house process. A second polymer stent was placed on a balloon and then inserted into the crimper. The crimper head was reduced to the stent's outer diameter. Then the balloon was inflated to stent's outer diameter or the crimper's inner diameter at the pressure of 30 psi. The stent was crimped down further under pressure or release pressure at a slow rate and then held at target crimping diameter for certain time without balloon pressure present.


Both groups were measured by Instron Tester. Bottom grip on the Instron held the balloons below the stent and the upper grip held a stent section on the balloons. The device was used to pull the stents away from the balloons by moving the upper grip in an upwards direction. The force was measured when the stents moved at least of 1 mm from the original location. FIG. 5 illustrates the result.


Example 2

A stent can be mounted on a balloon, followed by inflating the balloon to an inner diameter of the stent. Crimp to intermediate diameter, between original diameter of the stent and final, desired diameter of the stent. The balloon can then be deflated by pulling vacuum on balloon, for example. Next, the balloon can be inflated to an intermediate diameter (diameter is controlled by position of crimping head). Crimp to final, desired diameter. This method can provide support to the stent during the initial crimping process and reduces crimping defects during the manufacturing process.


While particular embodiments of the present invention have been described, it will be obvious to those skilled in the art that changes and modifications can be made without departing from the spirit and scope of the teachings and embodiments of this invention. Therefore, the appended claims are to encompass within their scope all such changes and modifications as fall within the true spirit of this invention.

Claims
  • 1. A method of crimping a stent onto a balloon of a catheter assembly, comprising: positioning a stent over a balloon of a catheter assembly;placing the stent and the balloon of the catheter assembly in a crimping device;inflating the balloon with an inflation fluid to a selected pressure, wherein the balloon has a rated burst pressure, and the selected pressure is greater than the rated burst pressure;crimping the stent to the balloon while the balloon is inflated to the selected pressure;releasing at least a portion of the inflation fluid from the balloon;after releasing at least a portion of the inflation fluid from the balloon, restraining the stent and the balloon with an outer sleeve; andafter restraining the stent and the balloon with the outer sleeve, applying pressure and heat to the stent and the balloon.
  • 2. The method of claim 1, wherein a wall of the balloon is pinched between stent struts across a length of the stent upon applying pressure and heat to the stent and the balloon.
  • 3. The method of claim 1, wherein a wall of the balloon is pinched between stent struts in a segmented manner across an entire length of the stent upon applying pressure and heat to the stent and the balloon.
  • 4. The method of claim 1, wherein crimping the stent to the balloon comprises applying a radially compressive force to the stent in an intermittent fashion.
  • 5. The method of claim 1, wherein crimping the stent comprises crimping the stent to a first reduced diameter.
  • 6. The method of claim 1, wherein inflating the balloon to the selected pressure is performed before placing the stent and the balloon of the catheter assembly in the crimping device.
  • 7. The method of claim 1, wherein inflating the balloon to the selected pressure is performed after placing the stent and the balloon of the catheter assembly in the crimping device.
  • 8. The method of claim 1, wherein inflating the balloon to the selected pressure is performed before crimping the stent to the balloon.
  • 9. The method of claim 1, wherein the inflation fluid is released from the balloon while crimping the stent to the balloon.
  • 10. The method of claim 9, wherein the inflation fluid is released from the balloon controllably by a valve.
  • 11. The method of claim 1, wherein a wall of the balloon protrudes between stent struts upon inflating the balloon to the selected pressure.
  • 12. The method of claim 1, wherein crimping the stent to the balloon comprises applying a radially compressive force to the stent.
  • 13. The method of claim 1, wherein the stent is a polymeric stent.
  • 14. The method of claim 1, wherein the stent is a biodegradable polymeric stent.
  • 15. The method of claim 1, wherein the stent is a biodegradable polymeric stent with a biodegradable metallic component.
  • 16. The method of claim 1, wherein the stent includes a drug coating.
  • 17. The method of claim 1, further comprising applying a solvent to the balloon.
  • 18. The method of claim 17, wherein the solvent comprises acetone.
  • 19. The method of claim 1, further comprising applying a balloon softening fluid to the balloon.
  • 20. The method of claim 1, wherein the balloon is inflated by a heated fluid.
  • 21. The method of claim 1, wherein the balloon is inflated by a cooled fluid.
REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/552,066, filed Nov. 24, 2014, which is a continuation of U.S. patent application Ser. No. 13/779,636, filed on Feb. 27, 2013, and now issued as U.S. Pat. No. 9,259,341 on Feb. 16, 2016; which is a continuation of U.S. patent application Ser. No. 13/551,538, filed on Jul. 17, 2012, and now issued as U.S. Pat. No. 8,925,177 on Jan. 6, 2015; which is a continuation application of U.S. patent application Ser. No. 11/471,375, filed on Jun. 19, 2006, and now issued as U.S. Pat. No. 8,333,000 on Dec. 18, 2012.

US Referenced Citations (428)
Number Name Date Kind
3687135 Stroganov et al. Aug 1972 A
3839743 Schwarcz Oct 1974 A
3900632 Robinson Aug 1975 A
4104410 Malecki Aug 1978 A
4110497 Hoel Aug 1978 A
4321711 Mano Mar 1982 A
4346028 Griffith Aug 1982 A
4596574 Urist Jun 1986 A
4599085 Riess et al. Jul 1986 A
4612009 Drobnik et al. Sep 1986 A
4633873 Dumican et al. Jan 1987 A
4656083 Hoffman et al. Apr 1987 A
4718907 Karwoski et al. Jan 1988 A
4722335 Vilasi Feb 1988 A
4723549 Wholey et al. Feb 1988 A
4732152 Wallsten et al. Mar 1988 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4740207 Kreamer Apr 1988 A
4743252 Martin, Jr. et al. May 1988 A
4768507 Fischell et al. Sep 1988 A
4776337 Palmaz Oct 1988 A
4800882 Gianturco Jan 1989 A
4816339 Tu et al. Mar 1989 A
4818559 Hama et al. Apr 1989 A
4850999 Planck Jul 1989 A
4877030 Beck et al. Oct 1989 A
4878906 Lindemann et al. Nov 1989 A
4879135 Greco et al. Nov 1989 A
4886062 Wiktor Dec 1989 A
4902289 Yannas Feb 1990 A
4977901 Ofstead Dec 1990 A
4990151 Wallsten Feb 1991 A
4994298 Yasuda Feb 1991 A
5019090 Pinchuk May 1991 A
5028597 Kodama et al. Jul 1991 A
5059211 Stack et al. Oct 1991 A
5062829 Pryor et al. Nov 1991 A
5084065 Weldon et al. Jan 1992 A
5085629 Goldberg et al. Feb 1992 A
5087244 Wolinsky et al. Feb 1992 A
5100429 Sinofsky et al. Mar 1992 A
5104410 Chowdhary Apr 1992 A
5108417 Sawyer Apr 1992 A
5108755 Daniels et al. Apr 1992 A
5112457 Marchant May 1992 A
5123917 Lee Jun 1992 A
5147385 Beck et al. Sep 1992 A
5156623 Hakamatsuka et al. Oct 1992 A
5163951 Pinchuk et al. Nov 1992 A
5163952 Froix Nov 1992 A
5163958 Pinchuk Nov 1992 A
5167614 Tessmann et al. Dec 1992 A
5192311 King et al. Mar 1993 A
5197977 Hoffman, Jr. et al. Mar 1993 A
5234456 Silvestrini Aug 1993 A
5234457 Andersen Aug 1993 A
5236447 Kubo et al. Aug 1993 A
5279594 Jackson Jan 1994 A
5282860 Matsuno et al. Feb 1994 A
5289831 Bosley Mar 1994 A
5290271 Jernberg Mar 1994 A
5292321 Lee Mar 1994 A
5306286 Stack et al. Apr 1994 A
5306294 Winston et al. Apr 1994 A
5328471 Slepian Jul 1994 A
5330500 Song Jul 1994 A
5342348 Kaplan Aug 1994 A
5342395 Jarrett et al. Aug 1994 A
5342621 Eury Aug 1994 A
5356433 Rowland et al. Oct 1994 A
5383925 Schmitt Jan 1995 A
5385580 Schmitt Jan 1995 A
5389106 Tower Feb 1995 A
5399666 Ford Mar 1995 A
5423885 Williams Jun 1995 A
5441515 Khosravi et al. Aug 1995 A
5443458 Eury et al. Aug 1995 A
5443500 Sigwart Aug 1995 A
5455040 Marchant Oct 1995 A
5464650 Berg et al. Nov 1995 A
5502158 Sinclair et al. Mar 1996 A
5507768 Lau et al. Apr 1996 A
5514154 Lau et al. May 1996 A
5514379 Weissieder et al. May 1996 A
5527337 Stack et al. Jun 1996 A
5545208 Wolff et al. Aug 1996 A
5545408 Trigg et al. Aug 1996 A
5549635 Solar Aug 1996 A
5554120 Chen et al. Sep 1996 A
5556413 Lam Sep 1996 A
5569295 Lam Oct 1996 A
5578046 Liu et al. Nov 1996 A
5578073 Haimovich et al. Nov 1996 A
5591199 Porter et al. Jan 1997 A
5591607 Gryaznov et al. Jan 1997 A
5593403 Buscemi Jan 1997 A
5593434 Williams Jan 1997 A
5599301 Jacobs et al. Feb 1997 A
5599922 Gryaznov et al. Feb 1997 A
5605696 Eury et al. Feb 1997 A
5607442 Fischell et al. Mar 1997 A
5607467 Froix Mar 1997 A
5618299 Khosravi et al. Apr 1997 A
5628784 Strecker May 1997 A
5629077 Turnlund et al. May 1997 A
5631135 Gryaznov et al. May 1997 A
5632771 Boatman et al. May 1997 A
5632840 Campbell May 1997 A
5637113 Tartaglia et al. Jun 1997 A
5649977 Campbell Jul 1997 A
5667767 Greff et al. Sep 1997 A
5667796 Otten Sep 1997 A
5670558 Onishi et al. Sep 1997 A
5690644 Yurek et al. Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5700286 Tartaglia et al. Dec 1997 A
5707385 Williams Jan 1998 A
5711763 Nonami et al. Jan 1998 A
5716393 Lindenberg et al. Feb 1998 A
5716981 Hunter et al. Feb 1998 A
5725549 Lam Mar 1998 A
5726297 Gryaznov et al. Mar 1998 A
5728068 Leone et al. Mar 1998 A
5728751 Patnaik Mar 1998 A
5733326 Tomonto et al. Mar 1998 A
5733330 Cox Mar 1998 A
5733564 Lehtinen Mar 1998 A
5733925 Kunz et al. Mar 1998 A
5741881 Patnaik Apr 1998 A
5756457 Wang et al. May 1998 A
5756476 Epstein et al. May 1998 A
5759474 Rupp et al. Jun 1998 A
5765682 Bley et al. Jun 1998 A
5766204 Porter et al. Jun 1998 A
5766239 Cox Jun 1998 A
5766710 Turnlund et al. Jun 1998 A
5769883 Buscemi et al. Jun 1998 A
5776140 Cottone Jul 1998 A
5780807 Saunders Jul 1998 A
5782839 Hart et al. Jul 1998 A
5792144 Fischell et al. Aug 1998 A
5800516 Fine et al. Sep 1998 A
5811447 Kunz et al. Sep 1998 A
5824049 Ragheb et al. Oct 1998 A
5830178 Jones et al. Nov 1998 A
5830461 Billiar Nov 1998 A
5830879 Isner Nov 1998 A
5833651 Donovan et al. Nov 1998 A
5834582 Sinclair et al. Nov 1998 A
5836962 Gianotti Nov 1998 A
5836965 Jendersee et al. Nov 1998 A
5837313 Ding et al. Nov 1998 A
5837835 Gryaznov et al. Nov 1998 A
5840083 Braach-Maksvytis Nov 1998 A
5851508 Greff et al. Dec 1998 A
5853408 Muni Dec 1998 A
5854207 Lee et al. Dec 1998 A
5855612 Ohthuki et al. Jan 1999 A
5855618 Patnaik et al. Jan 1999 A
5858746 Hubbell et al. Jan 1999 A
5860966 Tower Jan 1999 A
5865814 Tuch Feb 1999 A
5868781 Killion Feb 1999 A
5871468 Kramer et al. Feb 1999 A
5873904 Ragheb et al. Feb 1999 A
5874101 Zhong et al. Feb 1999 A
5874109 Ducheyne et al. Feb 1999 A
5874165 Drumheller Feb 1999 A
5876743 Ibsen et al. Mar 1999 A
5877263 Patnaik et al. Mar 1999 A
5879713 Roth et al. Mar 1999 A
5888533 Dunn Mar 1999 A
5891192 Murayama et al. Apr 1999 A
5893852 Morales Apr 1999 A
5897955 Drumheller Apr 1999 A
5906759 Richter May 1999 A
5913871 Werneth et al. Jun 1999 A
5914182 Drumheller Jun 1999 A
5916870 Lee et al. Jun 1999 A
5920975 Morales Jul 1999 A
5922005 Richter et al. Jul 1999 A
5942209 Leavitt et al. Aug 1999 A
5948428 Lee et al. Sep 1999 A
5954744 Phan et al. Sep 1999 A
5957975 Lafont et al. Sep 1999 A
5965720 Gryaznov et al. Oct 1999 A
5971954 Conway et al. Oct 1999 A
5976181 Whelan et al. Nov 1999 A
5976182 Cox Nov 1999 A
5980530 Willard et al. Nov 1999 A
5980564 Stinson Nov 1999 A
5980928 Terry Nov 1999 A
5980972 Ding Nov 1999 A
5981568 Kunz et al. Nov 1999 A
5986169 Gjunter Nov 1999 A
5997468 Wolff et al. Dec 1999 A
6010445 Armini et al. Jan 2000 A
6015541 Greff et al. Jan 2000 A
6022359 Frantzen Feb 2000 A
6042875 Ding et al. Mar 2000 A
6048964 Lee et al. Apr 2000 A
6051648 Rhee et al. Apr 2000 A
6056993 Leidner et al. May 2000 A
6060451 DiMaio et al. May 2000 A
6063092 Shin May 2000 A
6066156 Yan May 2000 A
6071266 Kelley Jun 2000 A
6074381 Dinh et al. Jun 2000 A
6074659 Kunz et al. Jun 2000 A
6080177 Igaki et al. Jun 2000 A
6080488 Hostettler et al. Jun 2000 A
6082990 Jackson et al. Jul 2000 A
6083258 Yadav Jul 2000 A
6093463 Thakrar Jul 2000 A
6096070 Ragheb et al. Aug 2000 A
6096525 Patnaik Aug 2000 A
6099562 Ding et al. Aug 2000 A
6103230 Billiar et al. Aug 2000 A
6106530 Harada Aug 2000 A
6107416 Patnaik et al. Aug 2000 A
6110180 Foreman et al. Aug 2000 A
6110188 Narciso, Jr. Aug 2000 A
6113629 Ken Sep 2000 A
6117979 Hendriks et al. Sep 2000 A
6120522 Vrba et al. Sep 2000 A
6120536 Ding et al. Sep 2000 A
6120904 Hostettler et al. Sep 2000 A
6121027 Clapper et al. Sep 2000 A
6125523 Brown et al. Oct 2000 A
6127173 Eckstein et al. Oct 2000 A
6129761 Hubbell Oct 2000 A
6129928 Sarangapani et al. Oct 2000 A
6141855 Morales Nov 2000 A
6150630 Perry et al. Nov 2000 A
6153252 Hossainy et al. Nov 2000 A
6159227 Di Caprio et al. Dec 2000 A
6159951 Karpeisky et al. Dec 2000 A
6160084 Langer et al. Dec 2000 A
6165212 Dereume et al. Dec 2000 A
6166130 Rhee et al. Dec 2000 A
6169170 Gryaznov et al. Jan 2001 B1
6171609 Kunz Jan 2001 B1
6174330 Stinson Jan 2001 B1
6177523 Reich et al. Jan 2001 B1
6183505 Mohn, Jr. et al. Feb 2001 B1
6187013 Stoltze et al. Feb 2001 B1
6187045 Fehring et al. Feb 2001 B1
6210715 Starling et al. Apr 2001 B1
6224626 Steinke May 2001 B1
6228845 Donovan et al. May 2001 B1
6240616 Yan Jun 2001 B1
6245076 Yan Jun 2001 B1
6245103 Stinson Jun 2001 B1
6248344 Yianen et al. Jun 2001 B1
6251135 Stinson et al. Jun 2001 B1
6251142 Bernacca et al. Jun 2001 B1
6264683 Stack et al. Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6273913 Wright et al. Aug 2001 B1
6280412 Pederson et al. Aug 2001 B1
6281262 Shikinami Aug 2001 B1
6284333 Wang et al. Sep 2001 B1
6287332 Bolz et al. Sep 2001 B1
6290721 Heath Sep 2001 B1
6293966 Frantzen Sep 2001 B1
6296655 Gaudion et al. Oct 2001 B1
6303901 Perry et al. Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6327772 Zadno-Azizi et al. Dec 2001 B1
6352547 Brown et al. Mar 2002 B1
6375660 Fischell et al. Apr 2002 B1
6375826 Wang et al. Apr 2002 B1
6379381 Hossainy et al. Apr 2002 B1
6387121 Alt May 2002 B1
6388043 Langer et al. May 2002 B1
6395326 Castro et al. May 2002 B1
6409761 Jang Jun 2002 B1
6423092 Datta et al. Jul 2002 B2
6461632 Gogolewski Oct 2002 B1
6464720 Boatman et al. Oct 2002 B2
6479565 Stanley Nov 2002 B1
6481262 Ching et al. Nov 2002 B2
6485512 Cheng Nov 2002 B1
6492615 Flanagan Dec 2002 B1
6494908 Huxel et al. Dec 2002 B1
6495156 Wenz et al. Dec 2002 B2
6510722 Ching et al. Jan 2003 B1
6511748 Barrows Jan 2003 B1
6517559 O'Connell Feb 2003 B1
6517888 Weber Feb 2003 B1
6527801 Dutta Mar 2003 B1
6537589 Chae et al. Mar 2003 B1
6539607 Fehring et al. Apr 2003 B1
6540777 Stenzel Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6554854 Flanagan Apr 2003 B1
6565599 Hong et al. May 2003 B1
6569191 Hogan May 2003 B1
6569193 Cox et al. May 2003 B1
6572672 Yadav et al. Jun 2003 B2
6574851 Mirizzi Jun 2003 B1
6579305 Lashinski Jun 2003 B1
6585755 Jackson et al. Jul 2003 B2
6592614 Lenker et al. Jul 2003 B2
6592617 Thompson Jul 2003 B2
6613072 Lau et al. Sep 2003 B2
6626939 Burnside et al. Sep 2003 B1
6635269 Jennissen Oct 2003 B1
6645243 Vallana et al. Nov 2003 B2
6656162 Santini, Jr. et al. Dec 2003 B2
6664335 Krishnan Dec 2003 B2
6666214 Canham Dec 2003 B2
6667049 Janas et al. Dec 2003 B2
6669723 Killion et al. Dec 2003 B2
6676697 Richter Jan 2004 B1
6679980 Andreacchi Jan 2004 B1
6689375 Wahlig et al. Feb 2004 B1
6695920 Pacetti et al. Feb 2004 B1
6706273 Roessier Mar 2004 B1
6709379 Brandau et al. Mar 2004 B1
6719934 Stinson Apr 2004 B2
6719989 Matsushima et al. Apr 2004 B1
6720402 Langer et al. Apr 2004 B2
6745445 Spilka Jun 2004 B2
6746773 Llanos et al. Jun 2004 B2
6752826 Holloway et al. Jun 2004 B2
6753007 Haggard et al. Jun 2004 B2
6764504 Wang et al. Jul 2004 B2
6764505 Hossainy et al. Jul 2004 B1
6769161 Brown et al. Aug 2004 B2
6818063 Kerrigan Nov 2004 B1
6846323 Yip et al. Jan 2005 B2
6863683 Schwager et al. Mar 2005 B2
7008446 Amis et al. Mar 2006 B1
7347869 Hojeibane et al. Mar 2008 B2
7470281 Tedeschi Dec 2008 B2
7563400 Wilson et al. Jul 2009 B2
7722663 Austin May 2010 B1
7731740 LaFont et al. Jun 2010 B2
7763198 Knott et al. Jul 2010 B2
7776926 Hossainy et al. Aug 2010 B1
7947207 Mcniven et al. May 2011 B2
8236039 Mackiewicz et al. Aug 2012 B2
8309023 Ramzipoor Nov 2012 B2
8333000 Huang et al. Dec 2012 B2
8512388 Roorda Aug 2013 B1
20010001128 Holman et al. May 2001 A1
20010044652 Moore Nov 2001 A1
20020002399 Huxel et al. Jan 2002 A1
20020004060 Heublein et al. Jan 2002 A1
20020004101 Ding et al. Jan 2002 A1
20020007207 Shin et al. Jan 2002 A1
20020035774 Austin Mar 2002 A1
20020062148 Hart May 2002 A1
20020065553 Weber May 2002 A1
20020068967 Drasler et al. Jun 2002 A1
20020111590 Davila et al. Aug 2002 A1
20020116050 Kocur Aug 2002 A1
20020138127 Stiger et al. Sep 2002 A1
20020138133 Lenz et al. Sep 2002 A1
20020161114 Gunatillake et al. Oct 2002 A1
20030033001 Igaki Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030055482 Schwager et al. Mar 2003 A1
20030056360 Brown et al. Mar 2003 A1
20030093107 Parsonage et al. May 2003 A1
20030097172 Shalev et al. May 2003 A1
20030100865 Santini, Jr. et al. May 2003 A1
20030105518 Dutta Jun 2003 A1
20030105530 Pirhonen Jun 2003 A1
20030171053 Sanders Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030208227 Thomas Nov 2003 A1
20030208259 Penhasi Nov 2003 A1
20030209835 Chun et al. Nov 2003 A1
20030212450 Schlick Nov 2003 A1
20030226833 Shapovalov et al. Dec 2003 A1
20030236563 Fifer Dec 2003 A1
20040073155 Laufer et al. Apr 2004 A1
20040093077 White et al. May 2004 A1
20040098095 Burnside et al. May 2004 A1
20040106973 Johnson Jun 2004 A1
20040111149 Stinson Jun 2004 A1
20040127880 Weber Jul 2004 A1
20040133263 Dusbabek et al. Jul 2004 A1
20040138731 Johnson Jul 2004 A1
20040143317 Stinson et al. Jul 2004 A1
20040167610 Fleming, III Aug 2004 A1
20040199246 Chu et al. Oct 2004 A1
20050096735 Hojeibane et al. May 2005 A1
20050118344 Pacetti Jun 2005 A1
20050143752 Schwager et al. Jun 2005 A1
20050154450 Larson et al. Jul 2005 A1
20050183259 Eidenschink et al. Aug 2005 A1
20050203606 VanCamp Sep 2005 A1
20050267408 Grandt et al. Dec 2005 A1
20050283962 Boudjemline Dec 2005 A1
20060004328 Joergensen et al. Jan 2006 A1
20060020285 Niermann Jan 2006 A1
20060030923 Gunderson Feb 2006 A1
20060041271 Bosma et al. Feb 2006 A1
20060047336 Gale et al. Mar 2006 A1
20060058863 LaFont et al. Mar 2006 A1
20060100694 Globerman May 2006 A1
20060229712 Wilson et al. Oct 2006 A1
20060287708 Ricci et al. Dec 2006 A1
20060288561 Roach et al. Dec 2006 A1
20070006441 Mcniven et al. Jan 2007 A1
20070204455 Boyd et al. Sep 2007 A1
20070208370 Hauser et al. Sep 2007 A1
20070255388 Rudakov et al. Nov 2007 A1
20070289117 Huang et al. Dec 2007 A1
20080097570 Thornton et al. Apr 2008 A1
20080208118 Goldman Aug 2008 A1
20090076448 Consigny et al. Mar 2009 A1
20090105747 Chanduszko et al. Apr 2009 A1
20090187210 Mackiewicz Jul 2009 A1
20090187211 Mackiewicz Jul 2009 A1
20090292347 Asmus et al. Nov 2009 A1
20100152765 Haley Jun 2010 A1
20110106234 Grandt May 2011 A1
20110257675 Mackiewicz Oct 2011 A1
20120035704 Grandt Feb 2012 A1
20120259402 Grandt Oct 2012 A1
20120283814 Huang et al. Nov 2012 A1
20130239396 Schwager et al. Sep 2013 A1
20130269168 Huang et al. Oct 2013 A1
Foreign Referenced Citations (64)
Number Date Country
44 07 079 Sep 1994 DE
195 09 464 Jun 1996 DE
197 31 021 Jan 1999 DE
198 56 983 Dec 1999 DE
0 108 171 May 1984 EP
0 144 534 Jun 1985 EP
0 364 787 Apr 1990 EP
0 397 500 Nov 1990 EP
0 464 755 Jan 1992 EP
0 493 788 Jul 1992 EP
0 554 082 Aug 1993 EP
0 578 998 Jan 1994 EP
0 604 022 Jun 1994 EP
0 621 017 Oct 1994 EP
0 623 354 Nov 1994 EP
0 665 023 Aug 1995 EP
0 709 068 May 1996 EP
0 716 836 Jun 1996 EP
0 787 020 Aug 1997 EP
0 935 952 Aug 1999 EP
0 970 711 Jan 2000 EP
1 000 591 May 2000 EP
1 226 798 Jul 2002 EP
1 295 570 Mar 2003 EP
1 637 177 Mar 2006 EP
2 029 052 Mar 2009 EP
2 196 174 Jun 2010 EP
2 322 118 May 2011 EP
2 247 696 Mar 1992 GB
WO 1989003232 Apr 1989 WO
WO 1990001969 Mar 1990 WO
WO 1990004982 May 1990 WO
WO 1990006094 Jun 1990 WO
WO 199117744 Nov 1991 WO
WO 199117789 Nov 1991 WO
WO 1992010218 Jun 1992 WO
WO 1993006792 Apr 1993 WO
WO 1994021196 Sep 1994 WO
WO 1995029647 Nov 1995 WO
WO 1998004415 Feb 1998 WO
WO 1999003515 Jan 1999 WO
WO 1999016382 Apr 1999 WO
WO 1999016386 Apr 1999 WO
WO 1999042147 Aug 1999 WO
WO 1999055255 Nov 1999 WO
WO 2000012147 Mar 2000 WO
WO 2000064506 Nov 2000 WO
WO 2000078249 Dec 2000 WO
WO 2001001890 Jan 2001 WO
WO 2001005462 Jan 2001 WO
WO 2001021110 Mar 2001 WO
WO 2002102283 Dec 2002 WO
WO 2004023985 Mar 2004 WO
WO 2004047681 Jun 2004 WO
WO 2005053937 Jun 2005 WO
WO 2006110861 Oct 2006 WO
WO 2007061927 May 2007 WO
WO 2008024491 Feb 2008 WO
WO 2008024621 Feb 2008 WO
WO 2008033621 Mar 2008 WO
WO 2009066330 May 2009 WO
WO 2009086205 Jul 2009 WO
WO 2010066446 Jun 2010 WO
WO 2011050979 May 2011 WO
Non-Patent Literature Citations (132)
Entry
U.S. Appl. No. 61/016,266, filed Dec. 21, 2007, Mackiewicz.
U.S. Appl. No. 61/138,455, filed Dec. 17, 2008, Haley.
U.S. Appl. No. 13/502,084, filed Oct. 29, 2010, Grandt.
U.S. Appl. No. 09/957,216, filed Sep. 19, 2001, U.S. Pat. No. 6,863,683, Mar. 8, 2005.
U.S. Appl. No. 11/064,692, filed Feb. 23, 2005, U.S. Pat. No. 9,295,570, Mar. 29, 2016.
U.S. Appl. No. 11/471,375, filed Jun. 29, 2006, U.S. Pat. No. 8,333,000, Dec. 18, 2012.
U.S. Appl. No. 13/551,538, filed Jul. 17, 2012, U.S. Pat. No. 8,925,177, Jan. 6, 2015.
U.S. Appl. No. 13/779,636, filed Feb. 27, 2013, U.S. Pat. No. 9,259,341, Feb. 16, 2016.
U.S. Appl. No. 13/779,683, filed Feb. 27, 2013, U.S. 2013/0239396, Sep. 19, 2013.
U.S. Appl. No. 14/552,066, filed Nov. 24, 2014, U.S. Pat. No. 9,579,225, Feb. 28, 2017.
U.S. Appl. No. 09/957,216, Jan. 31, 2005 Issue Fee payment.
U.S. Appl. No. 09/957,216, Feb. 16, 2005 Issue Notification.
U.S. Appl. No. 09/957,216, Nov. 4, 2004 Notice of Allowance.
U.S. Appl. No. 09/957,216, Sep. 17, 2004 Response to Non-Final Office Action.
U.S. Appl. No. 09/957,216, Jun. 14, 2004 Non-Final Office Action.
U.S. Appl. No. 09/957,216, Mar. 8, 2004 Response to Non-Final Office Action.
U.S. Appl. No. 09/957,216, Sep. 26, 2003 Non-Final Office Action.
U.S. Appl. No. 09/957,216, Aug. 4, 2003 Response to Restriction Requirement.
U.S. Appl. No. 09/957,216, Jun. 10, 2003 Restriction Requirement.
U.S. Appl. No. 11/064,692, Jul. 25, 2014 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Jan. 15, 2014 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Feb. 19, 2016 Issue Fee Payment.
U.S. Appl. No. 11/064,692, Nov. 19, 2015 Notice of Allowance.
U.S. Appl. No. 11/064,692, Aug. 3, 2015 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Apr. 1, 2015 Non-Final Office Action.
U.S. Appl. No. 11/064,692, Nov. 24, 2014 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/064,692, Aug. 26, 2014 Final Office Action.
U.S. Appl. No. 11/064,692, Jan. 7, 2014 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/064,692, Feb. 25, 2014 Non-Final Office Action.
U.S. Appl. No. 11/064,692, Oct. 2, 2013 Final Office Action.
U.S. Appl. No. 11/064,692, Sep. 10, 2013 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, May 10, 2013 Non-Final Office Action.
U.S. Appl. No. 11/064,692, Nov. 2, 2011 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/064,692, Aug. 2, 2011 Final Office Action.
U.S. Appl. No. 11/064,692, Jun. 29, 2011 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Mar. 29, 2011 Non-Final Office Action.
U.S. Appl. No. 11/064,692, Feb. 23, 2010 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/064,692, Nov. 23, 2009 Final Office Action.
U.S. Appl. No. 11/064,692, Jul. 31, 2009 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Mar. 31, 2009 Non-Final Office Action.
U.S. Appl. No. 11/064,692, Feb. 17, 2009 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/064,692, Oct. 14, 2008 Final Office Action.
U.S. Appl. No. 11/064,692, Jul. 21, 2008 Response to Non-Final Office Action.
U.S. Appl. No. 11/064,692, Feb. 21, 2008 Non-Final Office Action.
U.S. Appl. No. 11/471,375, Nov. 14, 2012 Issue Fee payment.
U.S. Appl. No. 11/471,375, Aug. 17, 2012 Notice of Allowance.
U.S. Appl. No. 11/471,375, Jun. 12, 2012 Response to Final Office Action.
U.S. Appl. No. 11/471,375, Apr. 13, 2012 Final Office Action.
U.S. Appl. No. 11/471,375, Mar. 8, 2012 Response to Non-Final Office Action.
U.S. Appl. No. 11/471,375, Dec. 8, 2011 Non-Final Office Action.
U.S. Appl. No. 11/471,375, Jun. 16, 2011 Response to Non-Final Office Action.
U.S. Appl. No. 11/471,375, Mar. 16, 2011 Non-Final Office Action.
U.S. Appl. No. 11/471,375, Jan. 18, 2011 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 11/471,375, Sep. 15, 2010 Final Office Action.
U.S. Appl. No. 11/471,375, Aug. 20, 2010 Response to Non-Final Office Action.
U.S. Appl. No. 11/471,375, Aug. 5, 2010 Non-Final Office Action.
U.S. Appl. No. 11/471,375, Mar. 29, 2010 Response to Non-Final Office Action.
U.S. Appl. No. 11/471,375, Feb. 2, 2010 Non-Final Office Action.
U.S. Appl. No. 11/471,375, Oct. 6, 2009 Response to Non-Final Office Action.
U.S. Appl. No. 11/471,375, Jul. 6, 2009 Non-Final Office Action.
U.S. Appl. No. 13/551,538, Nov. 13, 2013 Final Office Action.
U.S. Appl. No. 13/551,538, Sep. 10, 2013 Response to Non-Final Office Action.
U.S. Appl. No. 13/551,538, Jun. 10, 2013 Non-Final Office Action.
U.S. Appl. No. 13/551,538, Apr. 15, 2014 Non-Final Office Action.
U.S. Appl. No. 13/551,538, Jun. 19, 2014 Applicant Initiated Interview Summary.
U.S. Appl. No. 13/551,538, Jul. 15, 2014 Response to Non-Final Office Action.
U.S. Appl. No. 13/551,538, Sep. 19, 2014 Notice of Allowance.
U.S. Appl. No. 13/551,538, Nov. 24, 2014 Issue Fee Payment.
U.S. Appl. No. 13/779,636, Dec. 18, 2013 Non-Final Office Action.
U.S. Appl. No. 13/779,636, Aug. 22, 2014 Final Office Action.
U.S. Appl. No. 13/779,636, Nov. 24, 2014 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 13/779,636, Dec. 29, 2014 Non-Final Office Action.
U.S. Appl. No. 13/779,636, Mar. 30, 2015 Response to Non-Final Office Action.
U.S. Appl. No. 13/779,636, Jun. 5, 2015 Final Office Action.
U.S. Appl. No. 13/779,636, Sep. 4, 2015 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 13/779,636, Jan. 5, 2016 Issue Fee Payment.
U.S. Appl. No. 13/779,636, Oct. 5, 2015 Notice of Allowance.
U.S. Appl. No. 13/779,636, Sep. 10, 2015 Applicant Initiated Interview Summary.
U.S. Appl. No. 13/779,683, Mar. 7, 2017 Notice of Appeal Filed.
U.S. Appl. No. 13/779,683, Oct. 7, 2016 Final Office Action.
U.S. Appl. No. 13/779,683, Sep. 7, 2016 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 13/779,683, Apr. 7, 2016 Final Office Action.
U.S. Appl. No. 13/779,683, Jan. 29, 2016 Applicant Initiated Interview Summary.
U.S. Appl. No. 13/779,683, Jan. 26, 2016 Response to Non-Final Office Action.
U.S. Appl. No. 13/779,683, Sep. 25, 2015 Non-Final Office Action.
U.S. Appl. No. 13/779,683, Jun. 27, 2014 Applicant Initiated Interview Summary.
U.S. Appl. No. 14/552,066, Jan. 11, 2017 Issue Fee Payment.
U.S. Appl. No. 14/552,066, Oct. 11, 2016 Notice of Allowance
U.S. Appl. No. 14/552,066, Aug. 29, 2016 Amendment and Request for Continued Examination (RCE).
U.S. Appl. No. 14/552,066, Jun. 27, 2016 Response after Final Office Action.
U.S. Appl. No. 15/552,066, Apr. 27, 2016 Final Office Action.
U.S. Appl. No. 15/552,066, Feb. 1, 2016 Applicant Initiated Interview Summary.
U.S. Appl. No. 15/552,066, Jan. 29, 2016 Response to Non-Final Office Action.
U.S. Appl. No. 15/552,066, Jul. 29, 2015 Non-Final Office Action.
Anonymous, “Bioabsorbable stent mounted on a catheter having optical coherence tomography capabilities”, Research Disclosure, pp. 1159-1162, (2004).
Ansari, “End-to-end tubal anastomosis using an absorbable stent”, Fertility and Sterility, 32(2):197-201 (1979).
Ansari, “Tubal Reanastomosis Using Absorbable Stent”, International Journal of Fertility, 23(4):242-243 (1978).
Bull, “Parylene Coating for Medical Applications”, Medical Product Manufacturing News, 18:1 (1993).
Casper, et al., “Fiber-Reinforced Absorbable Composite for Orthopedic Surgery”, Polymeric Materials Science and Engineering, 53:497-501 (1985).
Detweiler, et al., “Gastrointestinal Sutureless Anastomosis Using Fibrin Glue: Reinforcement of the Sliding Absorbable Intraluminal Nontoxic Stent and Development of a Stent Placement Device”, Journal of Investigative Surgery, 9(2):111-130 (1996).
Detweiler, et al., “Sliding, Absorbable, Reinforced Ring and an Axially Driven Stent Placement Device for Sutureless Fibrin Glue Gastrointestinal Anastomisis”, Journal of Investigative Surgery, 9(6):495-504 (1996).
Detweiler, et al., “Sutureless Anastomosis of the Small Intestine and the Colon in Pigs Using an Absorbable Intraluminal Stent and Fibrin Glue”, Journal of Investigative Surgery, 8(2):129-140 (1995).
Detweiler, et al., “Sutureless Cholecystojejunostomu in Pigs Using an Absorbable Intraluminal Stent and Fibrin Glue”, Journal of Investigative Surgery, 9(1):13-26 (1996).
Devanathan, et al., “Polymeric Conformal Coatings for Implantable Electronic Devices”, IEEE Transactions on Biomedical Engineering, BME-27(11):671-675 (1980).
Elbert, et al., “Conjugate Addition Reactions Combined with Free-Radical Cross-Linking for the Design of Materials for Tissue Engineering”, Biomacromolecules, 2(2):430-441 (2001).
European Opposition dated Feb. 7, 2015 against European Patent EP 2066263.
European Search Report for EP Application No. 07809699.7, dated Jun. 12, 2009.
Hahn, et al., “Biocompatibility of Glow-Discharge-Polymerized Films and Vacuum-Deposited Parylene”, J Applied Polymer Sci, 38:55-64 (1984).
Hahn, et al., “Glow Discharge Polymers as Coatings for Implanted Devices”, ISA, pp. 109-111 (1981).
He, et al., “Assessment of Tissue Blood Flow Following Small Artery Welding with a Intraluminal Dissolvable Stent”, Microsurgery, 19(3):148-152 (1999).
International Search Report for PCT/US2007/014331, dated Dec. 28, 2007.
Kelley, et al., “Totally Resorbable High-Strength Composite Material”, Advances in Biomedical Polymers, 35:75-85 (1987).
Kubies, et al., “Microdomain Structure in polylactide-block-poly(ethylene oxide) copolymer films”, Biomaterials, 21(5):529-536 (2000).
Kutryk, et al., “Coronary Stenting: Current Perspectives”, a companion to the Handbook of Coronary Stents, pp. 1-16 (1999).
Martin, et al., “Enhancing the biological activity of immobilized osteopontin using a type-1 collagen affinity coating”, J. Biomed. Mater Res, 70A:10-19 (2004).
Mauduit, et al., “Hydrolytic degradation of films prepared from blends of high and low molecular weight poly(DL-lactic acid)s”, J. Biomed. Mater. Res., 30(2):201-207 (1996).
Middleton, et al., “Synthetic biodegradable polymers as orthopedic devices”, Biomaterials, 21(23):2335-2346 (2000).
Muller, et al., “Advances in Coronary Angioplasty: Endovascular Stents”, Coron. Arter. Dis., 1(4):438-448 (1990).
Nichols, et al., “Electrical Insulation of Implantable Devices by Composite Polymer Coatings”, ISA Transactions, 26(4):15-18 (1987).
Peuster, et al., “A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits”, Heart, 86(5):563-569 (2001).
Pietrzak, et al., “Bioabsorbable Fixation Devices: Status for the Craniomaxillofacial Surgeon”, J. Craniofaxial Surg., 8(2):92-96 (1997).
Pietrzak, et al., “Bioresorbable implants—practical considerations”, Bone, 19(1):109S-119S (Supplement Jul. 1996).
Redman, “Clinical Experience with Vasovasostomy Utilizing Absorbable Intravasal Stent”, Urology, 20(1):59-61 (1982).
Rust, et al., “The Effect of Absorbable Stenting on Postoperative Stenosis of the Surgically Enlarged Maxillary Sinus Ostia in a Rabbit Animal Model”, Archives of Otolaryngology, 122(12):1395-1397 (1996).
Schatz, “A View of Vascular Stants”, Circulation, 79(2):445-457 (1989).
Schmidt, et al., “Long-Term Implants of Parylene-C Coated Microelectrodes”, Med & Biol Eng & Comp, 26(1):96-101 (1988).
Spagnuolo, et al., “Gas 1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis”, Blood, 103(8):3005-3012 (2004).
Tamai, et al., “Initial and 6-Month Results of Biodegradable Poly-I-Lactic Acid Coronary Stents in Humans”, Circulation, 102(4):399-404 (2000).
Tsuji, et al., “Biodegradable Polymeric Stents”, Current Interventional Cardiology Reports, 3(1):10-17 (2001).
Volkel, et al., “Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin(CD105)”, Biochimica et Biophysica Acta, 1663(1-2):158-166 (2004).
Von Recum, et al., “Degradation of polydispersed poly(L-lactic acid) to modulate lactic acid release”, Biomaterials, 16(6):441-445 (1995).
Yau, et al., “Modern Size-Exclusion Liquid Chromatography”, Wiley-Interscience Publication, Table of Contents IX-XV (1979).
Related Publications (1)
Number Date Country
20170119564 A1 May 2017 US
Continuations (4)
Number Date Country
Parent 14552066 Nov 2014 US
Child 15403324 US
Parent 13779636 Feb 2013 US
Child 14552066 US
Parent 13551538 Jul 2012 US
Child 13779636 US
Parent 11471375 Jun 2006 US
Child 13551538 US